Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-043927
Filing Date
2005-09-13
Accepted
2005-09-13 17:05:42
Documents
11
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a05-16158_110k.htm 10-K 1540608
2 EX-10.29 a05-16158_1ex10d29.htm EX-10.29 407800
3 EX-10.30 a05-16158_1ex10d30.htm EX-10.30 484954
4 EX-10.31 a05-16158_1ex10d31.htm EX-10.31 127651
5 EX-23.1 a05-16158_1ex23d1.htm EX-23.1 5262
6 EX-23.2 a05-16158_1ex23d2.htm EX-23.2 3975
7 EX-31.1 a05-16158_1ex31d1.htm EX-31.1 10408
8 EX-31.2 a05-16158_1ex31d2.htm EX-31.2 10396
9 EX-32 a05-16158_1ex32.htm EX-32 9581
10 GRAPHIC g161581ka03i001.jpg GRAPHIC 1986
11 GRAPHIC g161581ba01i001.jpg GRAPHIC 17778
  Complete submission text file 0001104659-05-043927.txt   2629543
Mailing Address 1885 33RD STREET BOULDER CO 80301
Business Address 1885 33RD ST BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

EIN.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-16633 | Film No.: 051082765
SIC: 8071 Services-Medical Laboratories